Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.04
+0.01 (0.17%)
Nov 9, 2026, 2:38 PM EST - Market open

Inogen Revenue

Inogen had revenue of $77.19M in the quarter ending September 30, 2026, a decrease of -16.45%. This brings the company's total for the last twelve months to $339.11M, down -2.28% year-over-year. In the year 2025, Inogen had annual revenue of $348.67M with 3.86% growth. That makes Inogen the 13,381st largest company in the world by revenue and 2,502nd in the United States.

Revenue (ttm)
$339.11M
Revenue Growth
-2.28%
P/S Ratio
0.45
Revenue / Employee
$471,525
Employees
753
Market Cap
160.29M

Revenue Chart

Revenue by Geography

  • United States 209.84M 60.2%
  • Europe 118.00M 33.8%
  • Other International 20.82M 6.0%
Fiscal year ended Dec 31, 2025 See the full Inogen breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025348.67M12.96M3.86%
Dec 31, 2024335.71M20.05M6.35%
Dec 31, 2023315.66M-61.58M-16.32%
Dec 31, 2022377.24M19.24M5.37%
Dec 31, 2021358.00M49.52M16.05%
Dec 31, 2020308.49M-53.46M-14.77%
Dec 31, 2019361.94M3.83M1.07%
Dec 31, 2018358.11M108.67M43.57%
Dec 31, 2017249.44M46.61M22.98%
Dec 31, 2016202.83M43.82M27.56%
Dec 31, 2015159.01M46.47M41.29%
Dec 31, 2014112.54M37.09M49.17%
Dec 31, 201375.44M26.87M55.31%
Dec 31, 201248.58M17.94M58.57%
Dec 31, 201130.63M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Treace Medical Concepts203.35M
Neuronetics159.76M
Quanterix153.41M
RxSight121.83M
Owlet114.41M
Pulmonx88.78M
Standard BioTools84.43M
Electromed73.78M
Revenue Rankings